Orlando Luis Pardo Lazo

Title: Innovations by Orlando Luis Pardo Lazo

Introduction

Orlando Luis Pardo Lazo is a notable inventor based in Havana, Cuba. He has made significant contributions to the field of virology, particularly in the study of the dengue virus. His work focuses on the development of synthetic peptides and their potential applications in immunology.

Latest Patents

Orlando Luis Pardo Lazo holds a patent titled "Pre-M/M epitopes of dengue virus, synthetic peptides, chimeric proteins and their use." This invention relates to five synthetic peptides of the pre-M/M protein of the Dengue-2 virus, corresponding to amino acid sequences 3-31, 45-67, 57-92, 69-93, and 103-124. The anti-peptide immune response was evaluated in mice, demonstrating the potential for these peptides in eliciting neutralizing antibodies against the four serotypes of the dengue virus. The study also showed that mice immunized with specific conjugated peptides were protected when challenged with the Dengue-2 virus.

Career Highlights

Throughout his career, Orlando has focused on the intersection of synthetic biology and immunology. His research has contributed to a better understanding of the immune response to the dengue virus, paving the way for potential vaccine development. His innovative approach to studying viral proteins has garnered attention in the scientific community.

Collaborations

Orlando has collaborated with notable colleagues, including Glay Chinea Santiago and Ana Beatriz Perez Diaz. These partnerships have enhanced the scope and impact of his research, allowing for a multidisciplinary approach to tackling the challenges posed by viral infections.

Conclusion

Orlando Luis Pardo Lazo's work exemplifies the importance of innovation in the field of virology. His contributions to the understanding of the dengue virus through synthetic peptides highlight the potential for advancements in vaccine development and immunotherapy.